| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Africa needs to boost HPV vaccine uptake to stem rise in cervical cancer
|
Senior, Kathryn
|
|
|
24 |
9 |
p. 955
|
artikel
|
| 2 |
A legacy of war: cancer care fragmentation in Iraq
|
Balakrishnan, Vijay Shankar
|
|
|
24 |
9 |
p. 959
|
artikel
|
| 3 |
Avoidable mortality in the UK unlikely to change soon
|
The Lancet Oncology,
|
|
|
24 |
9 |
p. 945
|
artikel
|
| 4 |
Cancer research funding and care in the Philippines: gaps and ways forward
|
Feliciano, Katrina T
|
|
|
24 |
9 |
p. e360
|
artikel
|
| 5 |
Cancer risk estimates for US EPA-approved alternative plastic-based fuel cause alarm
|
Furlow, Bryant
|
|
|
24 |
9 |
p. 961
|
artikel
|
| 6 |
Choriocarcinoma masquerading as pulmonary embolism in a patient with a history of tuberculosis
|
Dai, Guan-Lin
|
|
|
24 |
9 |
p. e395
|
artikel
|
| 7 |
Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial
|
Umemura, Yoshie
|
|
|
24 |
9 |
p. 1042-1052
|
artikel
|
| 8 |
Combined gene therapies for high-grade glioma
|
Bernstock, Joshua D
|
|
|
24 |
9 |
p. 949-950
|
artikel
|
| 9 |
Correction to Lancet Oncology 2023; 24: 855–67
|
|
|
|
24 |
9 |
p. e361
|
artikel
|
| 10 |
Correction to Lancet Oncol 2023; published online July 27. https://doi.org/10.1016/S1470-2045(23)00381-9
|
|
|
|
24 |
9 |
p. e361
|
artikel
|
| 11 |
Dalpiciclib in advanced breast cancer: introducing CDK4/6 inhibitors as a first-line treatment might not be the best strategy
|
Hindié, Elif
|
|
|
24 |
9 |
p. e356
|
artikel
|
| 12 |
Dalpiciclib in advanced breast cancer: introducing CDK4/6 inhibitors as a first-line treatment might not be the best strategy – Author's reply
|
Xu, Binghe
|
|
|
24 |
9 |
p. e357
|
artikel
|
| 13 |
Effect of paediatric early warning systems (PEWS) implementation on clinical deterioration event mortality among children with cancer in resource-limited hospitals in Latin America: a prospective, multicentre cohort study
|
Agulnik, Asya
|
|
|
24 |
9 |
p. 978-988
|
artikel
|
| 14 |
Financial hardship in families of children or adolescents with cancer: a systematic literature review
|
Ritter, Julie
|
|
|
24 |
9 |
p. e364-e375
|
artikel
|
| 15 |
First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial
|
Özgüroğlu, Mustafa
|
|
|
24 |
9 |
p. 989-1001
|
artikel
|
| 16 |
Gauging radiotherapy resources in South America and the Caribbean
|
Alleyne-Mike, Kellie
|
|
|
24 |
9 |
p. 951-952
|
artikel
|
| 17 |
Gynaecological cancer waiting times in Northern Ireland
|
Venkatesan, Priya
|
|
|
24 |
9 |
p. 962
|
artikel
|
| 18 |
Improved cancer coverage for firefighters in Western Australia
|
Gourd, Elizabeth
|
|
|
24 |
9 |
p. 960
|
artikel
|
| 19 |
Incorporating absolute effects to enrich interpretation of findings from meta-analyses
|
Wu, Jing
|
|
|
24 |
9 |
p. e358
|
artikel
|
| 20 |
Incorporating absolute effects to enrich interpretation of findings from meta-analyses – Authors' reply
|
Petit, Claire
|
|
|
24 |
9 |
p. e359
|
artikel
|
| 21 |
Italy helps in Lebanon's cancer drug crisis
|
Das, Manjulika
|
|
|
24 |
9 |
p. 958
|
artikel
|
| 22 |
Medically assisted dying and cancer: a complex issue
|
Senior, Kathryn
|
|
|
24 |
9 |
p. e362
|
artikel
|
| 23 |
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study
|
Hurvitz, Sara A
|
|
|
24 |
9 |
p. 1029-1041
|
artikel
|
| 24 |
NICE approval of AI technology for radiotherapy contour planning
|
Wilkinson, Emma
|
|
|
24 |
9 |
p. e363
|
artikel
|
| 25 |
Precision medicine for children with cancer
|
Tannock, Ian F
|
|
|
24 |
9 |
p. 952-954
|
artikel
|
| 26 |
Radiotherapy resources in Latin America and the Caribbean: a review of current and projected needs based on International Atomic Energy Agency data
|
Elbanna, May
|
|
|
24 |
9 |
p. e376-e384
|
artikel
|
| 27 |
SERDs for primary breast cancer
|
Toi, Masakazu
|
|
|
24 |
9 |
p. 947-949
|
artikel
|
| 28 |
The global preventable cost of cancer drug wastage
|
Balakrishnan, Vijay Shankar
|
|
|
24 |
9 |
p. 956
|
artikel
|
| 29 |
Treatment-related mortality in children with cancer in low-income and middle-income countries: a systematic review and meta-analysis
|
Ehrlich, Bella S
|
|
|
24 |
9 |
p. 967-977
|
artikel
|
| 30 |
Tumor Treating Fields therapy could potentiate immunotherapy in non-small-cell lung cancer
|
Fennell, Dean A
|
|
|
24 |
9 |
p. 946-947
|
artikel
|
| 31 |
Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study
|
Leal, Ticiana
|
|
|
24 |
9 |
p. 1002-1017
|
artikel
|
| 32 |
Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial
|
Menon, Usha
|
|
|
24 |
9 |
p. 1018-1028
|
artikel
|
| 33 |
UK oncology approvals in 2022: global regulatory collaboration and new regulatory pathways deliver new anti-cancer therapies
|
Lythgoe, Mark P
|
|
|
24 |
9 |
p. 963-966
|
artikel
|
| 34 |
WHO's ninth report on the global tobacco epidemic
|
Samarasekera, Udani
|
|
|
24 |
9 |
p. 957
|
artikel
|
| 35 |
Withdrawn accelerated approvals for cancer indications in the USA: what is the marketing authorisation status in the EU?
|
Cramer, Allan
|
|
|
24 |
9 |
p. e385-e394
|
artikel
|
Tijdschrift beschrijving